VALIANT LABORATORIES
Back to Balance Sheet
|
VALIANT LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹109 Cr | ₹133 Cr | ₹196 Cr | ₹100 Cr |
What is the latest Net Current Assets ratio of VALIANT LABORATORIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹109 Cr |
| Mar2025 | ₹133 Cr |
| Mar2024 | ₹196 Cr |
| Mar2023 | ₹100 Cr |
How is Net Current Assets of VALIANT LABORATORIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹109 Cr | -18.14 | |
| Mar2025 | ₹133 Cr | -32.30 | |
| Mar2024 | ₹196 Cr | 96.76 | |
| Mar2023 | ₹100 Cr | - | |
Compare Net Current Assets of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹631.5 Cr | -7.7% | -4.2% | 40.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -7.7% |
-4.2% |
40.1% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses